Cargando…

Dementia in long-term Parkinson’s disease patients: a multicentre retrospective study

While several studies have investigated the clinical progression of cognitive decline in Parkinson’s disease (PD) patients, there has been a paucity of data on specifically evaluating PD patients with a disease duration of over 20 years. This study retrospectively investigated the frequency of demen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szeto, Jennifer Y. Y., Walton, Courtney C., Rizos, Alexandra, Martinez-Martin, Pablo, Halliday, Glenda M., Naismith, Sharon L., Chaudhuri, K. Ray, Lewis, Simon J. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946687/ https://www.ncbi.nlm.nih.gov/pubmed/31934610 http://dx.doi.org/10.1038/s41531-019-0106-4

Ejemplares similares

The relationships between mild cognitive impairment and phenotype in Parkinson’s disease
por: Szeto, Jennifer YY, et al.
Publicado: (2015)

Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia
por: Szeto, Jennifer Y.Y., et al.
Publicado: (2016)

Cognitive training for freezing of gait in Parkinson’s disease: a randomized controlled trial
por: Walton, Courtney C., et al.
Publicado: (2018)

Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
por: Chaudhuri, K. Ray, et al.
Publicado: (2013)

Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey
por: Rizos, A., et al.
Publicado: (2020)

Changes in Parkinson’s disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson’s disease
por: Kharkar, Siddharth, et al.
Publicado: (2018)

Stuck in the mud: time for change in the implementation of cognitive training research in ageing?
por: Walton, Courtney C., et al.
Publicado: (2014)

Identifying Parkinson’s disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering
por: Rodriguez-Sanchez, Fernando, et al.
Publicado: (2021)

Drooling in Parkinson’s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study
por: van Wamelen, Daniel J., et al.
Publicado: (2020)

Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale
por: Martinez-Martin, Pablo, et al.
Publicado: (2017)

The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review
por: Zis, Panagiotis, et al.
Publicado: (2015)

Mild Cognitive Impairment in Parkinson's Disease: A Review of Current Concepts
por: Palavra, Natalie C., et al.
Publicado: (2013)

Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
por: Titova, Nataliya, et al.
Publicado: (2017)

Dietary Variations in a Multiethnic Parkinson's Disease Cohort and Possible Influences on Nonmotor Aspects: A Cross-Sectional Multicentre Study
por: Sauerbier, Anna, et al.
Publicado: (2018)

Cognitive Function in Parkinson's Disease Patients with and without Anxiety
por: Ehgoetz Martens, K. A., et al.
Publicado: (2016)

Can we clinically diagnose dementia with Lewy bodies yet?
por: Huang, Yue, et al.
Publicado: (2013)

Aspects of Innate Immunity and Parkinson’s Disease
por: Huang, Yue, et al.
Publicado: (2012)

Quality of Life in Parkinson's Disease Caregivers: The Contribution of Personality Traits
por: Tew, Eloise H., et al.
Publicado: (2013)

Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients
por: Youssef, Priscilla, et al.
Publicado: (2021)

Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease
por: van Wamelen, Daniel J., et al.
Publicado: (2019)

Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
por: Voon, Valerie, et al.
Publicado: (2014)

Non-motor correlates of wrist-worn wearable sensor use in Parkinson’s disease: an exploratory analysis
por: van Wamelen, Daniel J., et al.
Publicado: (2019)

The Relationship between Thermoregulation and REM Sleep Behaviour Disorder in Parkinson’s Disease
por: Zhong, George, et al.
Publicado: (2013)

An Adaptive Measure of Visuospatial Impairment in Dementia with Lewy Bodies
por: Phillips, Joseph R., et al.
Publicado: (2022)

Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease
por: Galper, Jasmin, et al.
Publicado: (2022)

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
por: Postuma, Ronald B, et al.
Publicado: (2019)

Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria
por: Phillips, Joseph R., et al.
Publicado: (2022)

Parkinson’s: a syndrome rather than a disease?
por: Titova, Nataliya, et al.
Publicado: (2016)

Ethnic Disparities in Treatment of Chronic Pain in Individuals with Parkinson's Disease Living in the United Kingdom
por: Rukavina, Katarina, et al.
Publicado: (2022)

Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Evaluating a novel behavioral paradigm for visual hallucinations in Dementia with Lewy bodies
por: Phillips, Joseph R., et al.
Publicado: (2021)

Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson’s disease
por: Dafsari, Haidar S., et al.
Publicado: (2020)

Characterization of Non‐Motor Fluctuations Using the Movement Disorder Society Non‐Motor Rating Scale
por: van Wamelen, Daniel Johannes, et al.
Publicado: (2022)

Dynamic network impairments underlie cognitive fluctuations in Lewy body dementia
por: Matar, Elie, et al.
Publicado: (2022)

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
por: Oikonomou, Panteleimon, et al.
Publicado: (2021)

The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
por: Leta, Valentina, et al.
Publicado: (2023)

Objective Measurement of Daytime Napping, Cognitive Dysfunction and Subjective Sleepiness in Parkinson’s Disease
por: Bolitho, Samuel J., et al.
Publicado: (2013)

Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life
por: van Wamelen, Daniel J., et al.
Publicado: (2021)

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
por: Batzu, Lucia, et al.
Publicado: (2022)

Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
por: Youssef, Priscilla, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jqm9k81matm0dbs0fo94j3vtrc